BCRX

9.74

0.71% -0.07

Dopo l'orario di chiusura: 9.80 0.06 +0.62%

Biocryst Pharmaceuticals Inc (BCRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BCRX Giù? Forum Previsione

Precedente Chiudi:

$9.81

Aprire:

$9.68

Volume 24 ore:

3.82M

Relative Volume:

0.80

Capitalizzazione di mercato:

$2.49B

Reddito:

$885.72M

Utile/perdita netta:

$-457.98M

Rapporto P/E:

-5.4827

EPS:

-1.7765

Flusso di cassa netto:

$293.05M

1 W Prestazione:

+3.84%

1M Prestazione:

+0.00%

6M Prestazione:

+44.08%

1 anno Prestazione:

+15.27%

Intervallo 1D:

$9.46

$9.7999

Intervallo di 1 settimana:

$9.2801

$10.68

Portata 52W:

$6.00

$11.22

Biocryst Pharmaceuticals Inc Stock (BCRX) Company Profile

Nome

Biocryst Pharmaceuticals Inc

Settore

Healthcare (1080)

Industria

Drug Manufacturers - Specialty & Generic (87)

Telefono

919-859-1302

Indirizzo

4505 EMPEROR BOULEVARD, DURHAM, NC

Dipendente

435

Cinguettio

@biocrystpharma

Prossima data di guadagno

2026-08-05

Ultimi documenti SEC

BCRX's Discussions on Twitter

Compare BCRX vs TAK, TEVA, HLN, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BCRX Biocryst Pharmaceuticals Inc	9.74	2.71B	885.72M	-457.98M	293.05M	-1.7765
TAK Takeda Pharmaceutical Co Adr	17.63	55.60B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.77	42.81B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.70	43.16B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	73.79	30.39B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	499.73	21.95B	3.17B	1.29B	1.01B	27.09

Biocryst Pharmaceuticals Inc Stock (BCRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-18	Ripresa	Evercore ISI	Outperform
2025-10-15	Ripresa	TD Cowen	Buy
2025-10-01	Downgrade	Evercore ISI	Outperform → In-line
2025-04-29	Iniziato	Cantor Fitzgerald	Overweight
2025-02-25	Iniziato	Wedbush	Outperform
2023-11-20	Ripresa	JP Morgan	Overweight
2023-09-18	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2023-08-04	Aggiornamento	Jefferies	Hold → Buy
2023-07-13	Aggiornamento	BofA Securities	Neutral → Buy
2023-02-22	Aggiornamento	Needham	Hold → Buy
2022-11-02	Aggiornamento	Evercore ISI	In-line → Outperform
2022-08-05	Downgrade	Evercore ISI	Outperform → In-line
2022-08-05	Downgrade	Oppenheimer	Outperform → Perform
2022-04-18	Downgrade	Barclays	Overweight → Equal Weight
2022-04-11	Downgrade	BofA Securities	Buy → Neutral
2021-12-10	Iniziato	Oppenheimer	Outperform
2021-08-06	Downgrade	Jefferies	Buy → Hold
2021-08-03	Iniziato	Cantor Fitzgerald	Overweight
2021-03-01	Iniziato	Cowen	Outperform
2020-09-29	Ripresa	JP Morgan	Overweight
2020-06-17	Iniziato	BTIG Research	Neutral
2020-05-05	Aggiornamento	Barclays	Equal Weight → Overweight
2019-11-15	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2018-11-16	Ripresa	Piper Jaffray	Overweight
2018-08-08	Ripresa	JP Morgan	Overweight
2018-07-17	Aggiornamento	BofA/Merrill	Underperform → Neutral
2018-06-22	Iniziato	Seaport Global Securities	Neutral
2018-01-02	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2017-12-20	Iniziato	Barclays	Equal Weight
2017-09-15	Iniziato	RBC Capital Mkts	Sector Perform
2017-09-06	Aggiornamento	JP Morgan	Neutral → Overweight
2017-09-06	Aggiornamento	Jefferies	Hold → Buy
2017-02-16	Iniziato	Ladenburg Thalmann	Buy
2016-08-12	Aggiornamento	Piper Jaffray	Neutral → Overweight
2016-08-04	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2016-02-09	Reiterato	FBR Capital	Outperform
2016-02-09	Downgrade	JP Morgan	Overweight → Neutral
2016-02-09	Downgrade	Needham	Buy → Hold

Mostra tutto

Biocryst Pharmaceuticals Inc Borsa (BCRX) Ultime notizie

Aug 15, 2026

Why Did BCRX Stock Surge Over 10% In After-Hours Trading Today? - Stocktwits

Aug 15, 2026

How Investors May Respond To BioCryst (BCRX) Profit Swing, Raised Revenue Outlook And New ESOP Shares - simplywall.st

Aug 15, 2026

Aug 14, 2026

Discipline and Rules-Based Execution in BCRX Response - Stock Traders Daily

Aug 14, 2026

Biocryst Pharmaceuticals Stock Price Forecast. Should You Buy BCRX? - StockInvest.us

Aug 14, 2026

RA Capital discloses 6.2% BioCryst (BCRX) holding of 15.8M shares - Stock Titan

Aug 14, 2026

Research Analysts Issue Forecasts for BCRX Q4 Earnings - marketbeat.com

Aug 14, 2026

Wedge Capital Management L L P NC Acquires Shares of 380,801 BioCryst Pharmaceuticals, Inc. $BCRX - marketbeat.com

Aug 14, 2026

Aug 13, 2026

BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price Down 5.7%Here's What Happened - marketbeat.com

Aug 13, 2026

Why Did BioCryst Pharmaceuticals (BCRX) Shares Climb After Its Latest Update? - Yahoo Finance

Aug 13, 2026

BioCryst Pharmaceuticals (BCRX) Stock Looks Cheap Even After A 53% Gain - Yahoo Finance

Aug 13, 2026

Bank of America Corp DE Buys 3,556,208 Shares of BioCryst Pharmaceuticals, Inc. $BCRX - marketbeat.com

Aug 13, 2026

Assenagon Asset Management S.A. Buys 120,097 Shares of BioCryst Pharmaceuticals, Inc. $BCRX - marketbeat.com

Aug 13, 2026

Aug 12, 2026

BioCryst (BCRX) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 12, 2026

Wall Street Analysts See a 98.74% Upside in BioCryst (BCRX): Can the Stock Really Move This High? - Yahoo Finance

Aug 12, 2026

Aug 11, 2026

A Look at BioCryst Pharmaceuticals Inc (BCRX) After 5.1% Gain -- GF Value $12.76 vs Price $10.35 - GuruFocus

Aug 11, 2026

BioCryst Pharmaceuticals (NASDAQ:BCRX) Trading Up 6%What's Next? - marketbeat.com

Aug 11, 2026

Implied Volatility Surging for BioCryst Pharmaceuticals Stock Options - Yahoo Finance

Aug 11, 2026

A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst? - Yahoo Finance

Aug 11, 2026